The U.S is careening toward a potential recession, propelled by a dramatic escalation in trade barriers, including ...

It seems like a distant memory now, but 2025 began with an upbeat outlook, buoyed by deregulation and robust earnings. By ...

In this week’s video insight, I discuss the growth of Telix Pharmaceuticals (ASX:TLX). When the Montgomery Fund, The ...